171 related articles for article (PubMed ID: 2493700)
1. Induction of delayed hypersensitivity to alloantigens coinjected with Langerhans cells into the anterior chamber of the eye. Abrogation of anterior chamber-associated immune deviation.
Williamson JS; Streilein JW
Transplantation; 1989 Mar; 47(3):519-24. PubMed ID: 2493700
[TBL] [Abstract][Full Text] [Related]
2. Impaired induction of delayed hypersensitivity following anterior chamber inoculation of alloantigens.
Williamson JS; Streilein JW
Reg Immunol; 1988; 1(1):15-23. PubMed ID: 2978942
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the suppressor cell(s) responsible for anterior chamber-associated immune deviation (ACAID) induced in BALB/c mice by P815 cells.
Streilein JW; Niederkorn JY
J Immunol; 1985 Mar; 134(3):1381-7. PubMed ID: 3155766
[TBL] [Abstract][Full Text] [Related]
4. Exogenous recombinant interleukin-2 abrogates anterior-chamber-associated immune deviation.
Niederkorn JY
Transplantation; 1987 Apr; 43(4):523-8. PubMed ID: 2953091
[TBL] [Abstract][Full Text] [Related]
5. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
Kawashima H; Yamagami S; Tsuru T; Gregerson DS
Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-1 abrogates anterior chamber-associated immune deviation.
Benson JL; Niederkorn JY
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2123-8. PubMed ID: 1698740
[TBL] [Abstract][Full Text] [Related]
7. Splenic B cells are required for tolerogenic antigen presentation in the induction of anterior chamber-associated immune deviation (ACAID).
D'Orazio TJ; Niederkorn JY
Immunology; 1998 Sep; 95(1):47-55. PubMed ID: 9767456
[TBL] [Abstract][Full Text] [Related]
8. Alloantigen presentation to the anterior chamber of the eye subverts specific in vitro cell-mediated immune responses.
Whittum JA; Niederkorn JY; Streilein JW
Transplantation; 1982 Oct; 34(4):190-5. PubMed ID: 6183804
[TBL] [Abstract][Full Text] [Related]
9. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
Wilbanks GA; Mammolenti M; Streilein JW
Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
[TBL] [Abstract][Full Text] [Related]
10. Studies on the induction of anterior chamber-associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID.
Wilbanks GA; Mammolenti M; Streilein JW
J Immunol; 1991 May; 146(9):3018-24. PubMed ID: 2016537
[TBL] [Abstract][Full Text] [Related]
11. Alloantigens introduced into the anterior chamber of the eye induce systemic suppression of delayed hypersensitivity to third-party alloantigens through "linked recognition".
Niederkorn JY; Mayhew E; He Y
Transplantation; 1995 Aug; 60(4):348-54. PubMed ID: 7652764
[TBL] [Abstract][Full Text] [Related]
12. Antigen presentation by Langerhans cells in vivo: donor-derived Ia+ Langerhans cells are required for induction of delayed-type hypersensitivity but not for cytotoxic T lymphocyte responses to alloantigens.
Peeler JS; Niederkorn JY
J Immunol; 1986 Jun; 136(12):4362-71. PubMed ID: 3519767
[TBL] [Abstract][Full Text] [Related]
13. Immunobiology of Langerhans cells on the ocular surface. I. Langerhans cells within the central cornea interfere with induction of anterior chamber associated immune deviation.
Williamson JS; DiMarco S; Streilein JW
Invest Ophthalmol Vis Sci; 1987 Sep; 28(9):1527-32. PubMed ID: 3623837
[TBL] [Abstract][Full Text] [Related]
14. Immune privilege in the anterior chamber of the eye: alloantigens and tumour-specific antigens presented into the anterior chamber simultaneously induce suppression and activation of delayed hypersensitivity to the respective antigens.
Benson JL; Niederkorn JY
Immunology; 1992 Oct; 77(2):189-95. PubMed ID: 1427974
[TBL] [Abstract][Full Text] [Related]
15. The presence of donor-derived class II-positive cells abolishes immune privilege in the anterior chamber of the eye.
Benson JL; Niederkorn JY
Transplantation; 1991 Apr; 51(4):834-8. PubMed ID: 2014538
[TBL] [Abstract][Full Text] [Related]
16. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
17. Splenic B cells act as antigen presenting cells for the induction of anterior chamber-associated immune deviation.
Skelsey ME; Mayhew E; Niederkorn JY
Invest Ophthalmol Vis Sci; 2003 Dec; 44(12):5242-51. PubMed ID: 14638723
[TBL] [Abstract][Full Text] [Related]
18. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
Wilbanks GA; Streilein JW
J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
[TBL] [Abstract][Full Text] [Related]
19. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type.
Hara Y; Okamoto S; Rouse B; Streilein JW
J Immunol; 1993 Nov; 151(10):5162-71. PubMed ID: 8228216
[TBL] [Abstract][Full Text] [Related]
20. Ocular immune privilege promoted by the presentation of peptide on tolerogenic B cells in the spleen. II. Evidence for presentation by Qa-1.
D'Orazio TJ; Mayhew E; Niederkorn JY
J Immunol; 2001 Jan; 166(1):26-32. PubMed ID: 11123273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
